SPINRAZA (nusinersen) EU label will include information on the potential risk of hydrocephalus

Biogen published the following information and address your questions and concerns about the upcoming SPINRAZA (nusinersen) EU label (Prescribing information and Package Leaflet) update that will include information on the potential risk of hydrocephalus. All medicines are evaluated for the benefit they provide to patients as well as the potential … Fortsätt läsa SPINRAZA (nusinersen) EU label will include information on the potential risk of hydrocephalus